Diagnostic performances and cut-off verification of blood pTau 217 on the Lumipulse platform for amyloid deposition in Alzheimer's disease

Clin Chem Lab Med. 2024 Nov 13. doi: 10.1515/cclm-2024-1091. Online ahead of print.

Giulia Musso^{1

2}, Carlo Gabelli³, Annachiara Cagnin^{4

5}, Chiara Cosma¹, Diego Cecchin^{5

6}, Giovanni Zorzi³, Martina Zaninotto⁷, Valentina Misenti⁴, Angelo Antonini^{4

5}, Mario Plebani^{1

7}, Daniela Basso^{1

2}

¹ Department of Medicine - DIMED, University of Padova, Padova, Italy.
² Laboratory Medicine, University-Hospital of Padova, Padova, Italy.
³ Regional Brain Aging Center, University-Hospital of Padova, Padova, Italy.
⁴ Department of Neurosciences, University of Padova, Padova, Italy.
⁵ Padua Neuroscience Center (PNC), University of Padova, Padova, Italy.
⁶ Department of Medicine (DIMED), Nuclear Medicine Unit, University of Padova, Padova, Italy.
⁷ QI.LAB.MED, Spin-off of the University of Padova, Padova, Italy.

No abstract available

Keywords: Alzheimer’s disease; blood biomarkers; chemiluminescence; diagnostic performances; pTau 217.

Publication types